During the past decade, Universitätsklinikum Freiburg, Frauenklinik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Freiburg, Frauenklinik" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "AGO Study Group" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "Arcagy Research" with 1 trials sponsored and "Canadian Cancer Trials Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Freiburg, Frauenklinik" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "Grupo Español de Investigación en Cáncer de Ovario" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Freiburg, Frauenklinik" are "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (3 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Universitätsklinikum Freiburg, Frauenklinik" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Freiburg, Frauenklinik" are "Drug" (8 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Placebo" (2 trials), "Atezolizumab" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Freiburg, Frauenklinik" are 8 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Freiburg, Frauenklinik". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Universitätsklinikum Freiburg, Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Freiburg, Frauenklinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".